ENGN Q4 2024 Earnings — enGene Holdings Inc. Revenue & Financial Results | Market Cap Arena

ENGNenGene Holdings Inc.

$359M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$480,000

Gross Profit

$240,00050.0% margin

Operating Income

-$17M-3636.5% margin

Net Income

-$15M-3187.3% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$311M

Total Liabilities

$39M

Stockholders' Equity

$273M

Cash & Equivalents

$173M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$480,000	$0	—
Gross Profit	$240,000	$0	—
Operating Income	-$17M	-$10M	-67.2%
Net Income	-$15M	-$82M	+81.5%